Cita APA (7a ed.)

Z, W., W, L., F, L., T, Y., W, X., M, L., . . . Y, Z. (2021). Downregulation of lncRNA EPB41L4A-AS1 Mediates Activation of MYD88-Dependent NF-κB Pathway in Diabetes-Related Inflammation. Dove Medical Press.

Cita Chicago Style (17a ed.)

Z, Wang, Liao W, Liu F, Yang T, Xie W, Liao M, Gu D, y Zhang Y. Downregulation of LncRNA EPB41L4A-AS1 Mediates Activation of MYD88-Dependent NF-κB Pathway in Diabetes-Related Inflammation. Dove Medical Press, 2021.

Cita MLA (8a ed.)

Z, Wang, et al. Downregulation of LncRNA EPB41L4A-AS1 Mediates Activation of MYD88-Dependent NF-κB Pathway in Diabetes-Related Inflammation. Dove Medical Press, 2021.

Precaución: Estas citas no son 100% exactas.